Testing effectiveness (Phase 2)Not Yet RecruitingNCT06769984What this trial is testingSCTT11 in Healthy Participants and Participants with Thyroid Eye Disease.Who this might be right forTED Sinocelltech Ltd. 100
Post-approval studies (Phase 4)Looking for participantsNCT07152340What this trial is testingThe Safety and Efficacy of Sequential Hormone Therapy and IBI311 Therapy in Patients With Active Moderate to Severe TAO in the Initial Treatment.Who this might be right forThyroid Associated Ophthalmopathies Shanghai Changzheng Hospital 64
Testing effectiveness (Phase 2)Study completedNCT00954057What this trial is testingPilot Study to Determine Safety and Efficacy of Orbital Injections of LIPO-102 in Patients With Symptomatic Exophthalmos Associated With Thyroid-related Eye Disease (TED)Who this might be right forThyroid-Related Eye Disease Neothetics, Inc 11
Large-scale testing (Phase 3)Looking for participantsNCT06112340What this trial is testingExtension Study of Two Doses of Linsitinib in Subjects With Active, Moderate to Severe Thyroid Eye Disease (TED)Who this might be right forThyroid Eye DiseaseGraves OrbitopathyEndocrine System Diseases+9 more Sling Therapeutics, Inc. 75
Large-scale testing (Phase 3)Active Not RecruitingNCT05517447What this trial is testingExtension Study to Assess Batoclimab in Participants With Thyroid Eye DiseaseWho this might be right forThyroid Eye Disease Immunovant Sciences GmbH 180
Not applicableStudy completedNCT07056114What this trial is testingMulti-modal Medical Images for Extraocular Muscle Fibrosis AssessmentWho this might be right forThyroid Eye Disease, TED Tianjin Eye Hospital 58
Large-scale testing (Phase 3)Study completedNCT05517421What this trial is testingStudy to Assess Batoclimab in Participants With Active Thyroid Eye DiseaseWho this might be right forThyroid Eye Disease Immunovant Sciences GmbH 114
Early research (Phase 1)Study completedNCT07142642What this trial is testingEvaluate Pharmacokinetics, Safety, and Tolerability of Teprotumumab (AMG 632) Administered Intravenously in Healthy Chinese ParticipantsWho this might be right forHealthy Volunteers Amgen 20
Large-scale testing (Phase 3)Study completedNCT06384547What this trial is testingA Randomized, Controlled, Safety and Tolerability Study of VRDN-001 in Participants With Thyroid Eye Disease (TED)Who this might be right forThyroid Eye Disease Viridian Therapeutics, Inc. 231
Large-scale testing (Phase 3)Looking for participantsNCT07257185What this trial is testingMHB018A Treatment in Patients With Chronic Thyroid Eye DiseaseWho this might be right forThyroid Eye Disease (TED) Minghui Pharmaceutical (Hangzhou) Ltd 150
Post-approval studies (Phase 4)Not Yet RecruitingNCT07308964What this trial is testingComparison of the Efficacy and Safety of 4 vs. 8 Treatments With Tepezza (Teprotumumab) for Thyroid Eye DiseaseWho this might be right forThyroid Eye DiseaseThyroid Eye Disease, TEDThyroid Eye Disease (TED) Sheba Medical Center 40
Large-scale testing (Phase 3)Active Not RecruitingNCT05276063What this trial is testingA Phase 2b, Study of Linsitinib in Subjects With Active, Moderate to Severe Thyroid Eye Disease (TED)Who this might be right forThyroid Eye DiseaseGraves OrbitopathyEndocrine System Diseases+9 more Sling Therapeutics, Inc. 90
Early research (Phase 1)Ended earlyNCT06467435What this trial is testingEvaluation of K9 in Subjects With Thyroid Eye Disease (TED)Who this might be right forThyroid Eye Disease Peter Timoney 4
Not applicableStudy completedNCT07471997What this trial is testingTriamcinolone Acetonide Injection for Upper Eyelid Retraction in Thyroid Eye DiseaseWho this might be right forThyroid Eye Disease, TED Instituto de Oftalmología Fundación Conde de Valenciana 15
Large-scale testing (Phase 3)Active Not RecruitingNCT06126783What this trial is testingA Multicenter, Open-label Extension Study Evaluating the Efficacy and Safety of IBI311 in Subjects With Thyroid Eye DiseaseWho this might be right forThyroid Eye Disease, TED Innovent Biologics (Suzhou) Co. Ltd. 91
Large-scale testing (Phase 3)UnknownNCT05015127What this trial is testingEvaluate the Efficacy and Safety of HBM9161 on Moderate to Severe Thyroid Eye DiseaseWho this might be right forThyroid Ophthalmopathy Harbour BioMed (Guangzhou) Co. Ltd. 36
Large-scale testing (Phase 3)Active Not RecruitingNCT05987423What this trial is testingEvaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Satralizumab in Participants With Thyroid Eye DiseaseWho this might be right forThyroid Eye DiseaseTED Hoffmann-La Roche 131
Post-approval studies (Phase 4)Study completedNCT05002998What this trial is testingTEPEZZA® (Teprotumumab-trbw) Post-Marketing Requirement StudyWho this might be right forThyroid Eye Disease Amgen 313
Early research (Phase 1)Looking for participantsNCT06569758What this trial is testingGenSci098 in Subjects With Active Thyroid Eye DiseaseWho this might be right forSafetyTolerabilityGenSci098+1 more Changchun GeneScience Pharmaceutical Co., Ltd. 76
Large-scale testing (Phase 3)Study completedNCT06021054What this trial is testingAn Efficacy, Safety, and Tolerability Study of Veligrotug (VRDN-001), in Participants With Chronic Thyroid Eye Disease (TED) (THRIVE-2)Who this might be right forThyroid Eye Disease Viridian Therapeutics, Inc. 188